TI Deprescribing Webinar Series

05 Dec 2023 TI Deprescribing Webinar Series

Share
Posted at 19:44h in Blog, Education by

When challenged by complex cases involving people taking too many medications, we may ask:

  • Can I stop any of these?
  • Which should I stop first?
  • Do I need to taper this drug? If so, how?
  • What should I monitor for after stopping, and when?

Many clinicians address these clinical questions successfully, improving outcomes for patients.  Sometimes, things don’t work out as we hope.  At the Therapeutics Initiative, we want to create a platform for healthcare providers, patients, caregivers, advocates and policy makers to learn from each other about successes and challenges in deprescribing.  Learning together, we hope to build confidence and knowledge about deprescribing in BC and beyond. To that aim, we created the TI Deprescribing Webinar Series. Each 1-hour session includes presentations of 2 cases by the clinicians who did the deprescribing, often illustrated by videos (shared with the patients’ consent). Time is allocated for the participants to ask questions and share their own experiences. Over 2,000 people signed up for one of the first five webinars held in 2023 and we intend to continue the series in 2024.

Five sessions in the TI Deprescribing Webinar Series were held in 2023, a sixth was held in March 2024 and the seventh is scheduled for June 12, 2024 (links include the slide decks and video recording for each session):

CME CREDITS: MainPro+/MOC Section 1 credits: 1.0 per session. Those who registered, attended a webinar and completed the evaluation will receive their certificate.

LEARNING OBJECTIVES

By the end of each presentation, attendees will be able to:

  1. Recognize when a medication list is not appropriate for a patient’s long-term health
  2. Begin to develop a plan to simplify by deprescribing potentially harmful or redundant drugs.
  3. Identify helpful collaborators (pharmacists, specialists, or other colleagues) who can assist with successful deprescribing

The TI Deprescribing Webinars are coordinated by:

Tom Perry MD, FRCPC
Clinical Associate Professor, Department of AP&T, UBC
Co-Chair, Education Working Group, UBC Therapeutics Initiative
tom.perry@ubc.ca

Wade Thompson PharmD, PhD
Assistant Professor, Department of AP&T, UBC
Organizer, International Deprescribing Conference
Education Working Group, UBC Therapeutics Initiative
wade.thompson@ubc.ca

INVITATION TO SUBMIT & PRESENT A CASE AT FUTURE WEBINARS!

Please let colleagues or friends know about this new webinar series.

  • We host a 1-hour case-based webinar every 2 months (except August).  The initial schedule is Wednesdays at 12:00-13:00 h Pacific Time, but we may vary this in future, depending on demand.
  • Deprescribing Webinars are open to pharmacists, doctors, nurse practitioners, nurses, health profession students, patients & care providers, and others in health care who are interested in how to address undesirable polypharmacy effectively through responsible deprescribing.
  • The Webinars are case-based.  We invite case submissions from any health profession (including students, and potentially from patients/caregivers who wish to share their experiences).  As in any health care setting, we expect our audience to respect the confidentiality of information presented with informed patient consent.

Who should submit?

  • Nursing, psych nursing, NP, medical, and pharmacy students or residents;
  • Recently qualified practitioners working in hospital, community, or long-term care who identify a deprescribing problem or success they think will interest others;
  • Senior clinicians in any health care field who want to share their acumen and experience with deprescribing clinical logic, pharmacokinetics, avoiding withdrawal, teaching others how to deprescribe successfully, use of electronic aides or AI;
  • Patients or families who think their story may enlighten health professionals.

What will you need to submit a case?

  • Patient consent to present anonymized relevant history, physical findings, drug list;
  • Consent of your supervisor if relevant (e.g. students/residents);
  • Obtain key details including all medications and doses, relevant vital signs (e.g.supine & standing BP and HR, RR and SaO2) while you have authorized access to patient record.

If interested, please contact Dr. Perry or Dr. Thompson at the emails above.  We will work with submitters to develop succinct, effective presentations that allow time for audience discussion in Zoom Chat, Q&A, and through our moderators.  If you wish to propose a case, don’t be shy! DO respect patient privacy – don’t disclose any information that could identify an individual.  Dr. Perry can discuss possible case presentations by telephone, if you email him.

No Comments

Post A Comment